Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

20.05
-0.0100-0.05%
Volume:772.76K
Turnover:15.67M
Market Cap:3.20B
PE:-7.07
High:20.65
Open:20.57
Low:19.90
Close:20.06
52wk High:27.30
52wk Low:12.58
Shares:159.85M
Float Shares:151.07M
Volume Ratio:0.60
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:3.84
PE(LYR):-6.75

Loading ...

Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 05, 2022

Major Issues Report

8-K - Current report
Jun 03, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 16, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities